Physician profile
Thomas Dzwonczyk
NPI 1760487060
$1,851.49
in general payments reported to CMS, 2019-2025
19 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.42 · 2020: $15.76 · 2021: $125 · 2022: $318 · 2023: $832 · 2024: $267 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,365.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $541.58 | 2021-2025 | |
| Boston Scientific Corporation | $414.84 | 2019-2024 | Avvigo Guidance System, Synergy |
| Edwards Lifesciences Corporation | $330.17 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $115.41 | 2022-2023 | Aveir |
| E.R. Squibb & Sons, L.L.C. | $75.11 | 2023-2025 | Eliquis |
| Baxter Healthcare | $68.20 | 2022 | |
| Abiomed | $49.11 | 2025 | |
| Medtronic, INC. | $39.61 | 2021-2025 | Corevalve Evolut R |
| Pfizer INC. | $38.12 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $32.06 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $20.37 | 2023 | Verquvo |
| Alnylam Pharmaceuticals INC. | $19.93 | 2024 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $19.81 | 2023 | Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.43 | 2023 | Jardiance |
| Kiniksa Pharmaceuticals, LTD. | $16.54 | 2023 | Arcalyst |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.91 | 2025 | Wegovy |
| Esperion Therapeutics, INC. | $15.29 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.66 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.34 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Dzwonczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.